The reduction or dephosphorylation of Cav-1 can release Mfn2 and Drp1, promote mitochondrial dynamics and mitophagy, and reduce the accumulation of damaged mitochondria, thereby enabling cancer cell survival and affecting cancer treatment (84). Here, MFN2 is linked to cancer.